Karam Karam, Mitri Samia, Azizi Lamia, Fiani Elias
Department of Gastroenterology, University of Balamand, Beirut, Lebanon.
Department of Internal Medicine, University of Balamand, Beirut, Lebanon.
Eur J Case Rep Intern Med. 2024 Sep 16;11(10):004829. doi: 10.12890/2024_004829. eCollection 2024.
Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with an array of intestinal injuries: erosions, ulcers, enteropathy, strictures and diaphragm disease. The diagnosis of diaphragm disease is challenging. Diaphragm disease can cause thin, concentric and stenosing strictures, which can induce intermittent or complete bowel obstruction. NSAID-induced lesions are reversible following discontinuation of the offending agent. Treatment of diaphragm disease can be conservative, endoscopic or surgical through stricturoplasty and/or segmental resection. We report a case of a 59-year-old female presenting with intermittent right lower quadrant pain diagnosed with diaphragm disease upon combined ileo-colonoscopy and histopathological analysis. Her diaphragm disease was successfully treated conservatively through drug cessation, avoiding more invasive procedures like endoscopic and surgical interventions.
The incidence of diaphragm disease has been soaring due to the widespread use of non-steroidal anti-inflammatory drugs (NSAIDs).Diaphragm disease is characterized by diaphragm-like mucosal projections and annular constrictions that induce luminal narrowing and result in bowel obstruction.Physicians should get acquainted with diaphragm disease and include it in their differential diagnosis when approaching a patient with obstruction-like symptoms or non-specific and vague abdominal pain in the setting of chronic NSAIDs usage.
非甾体抗炎药(NSAIDs)与一系列肠道损伤有关:糜烂、溃疡、肠病、狭窄和膈病。膈病的诊断具有挑战性。膈病可导致薄的、同心性的和狭窄性狭窄,可引起间歇性或完全性肠梗阻。停用致病药物后,NSAID引起的病变是可逆的。膈病的治疗可以是保守的、内镜的或通过狭窄成形术和/或节段性切除进行手术治疗。我们报告一例59岁女性,因间歇性右下腹疼痛就诊,经回结肠镜检查和组织病理学分析诊断为膈病。通过停药成功地对其膈病进行了保守治疗,避免了内镜和手术干预等更具侵入性的操作。
由于非甾体抗炎药(NSAIDs)的广泛使用,膈病的发病率一直在飙升。膈病的特征是类似膈的黏膜突起和环形狭窄,导致管腔狭窄并引起肠梗阻。医生应熟悉膈病,并在处理有梗阻样症状的患者或在慢性使用NSAIDs情况下出现非特异性和模糊腹痛的患者时,将其纳入鉴别诊断。